Skip to Content

SEC Filing

Document Details

Filing Date
Apr 3, 2024
Document Date
Apr 3, 2024
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
Kinnate Biopharma
Issuer
Kinnate Biopharma Inc.